학술논문
A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma
Document Type
Article
Author
Source
In Clinical Lymphoma Myeloma and Leukemia January 2018 18(1):e51-e60
Subject
Language
ISSN
2152-2650